Does RISANKIZUMAB-RZAA Cause Cellulitis? 253 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 253 reports of Cellulitis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.4% of all adverse event reports for RISANKIZUMAB-RZAA.
253
Reports of Cellulitis with RISANKIZUMAB-RZAA
0.4%
of all RISANKIZUMAB-RZAA reports
2
Deaths
151
Hospitalizations
How Dangerous Is Cellulitis From RISANKIZUMAB-RZAA?
Of the 253 reports, 2 (0.8%) resulted in death, 151 (59.7%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Cellulitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 253 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Cellulitis?
ADALIMUMAB (1,918)
METHOTREXATE (1,395)
ETANERCEPT (1,261)
LENALIDOMIDE (1,255)
SECUKINUMAB (1,168)
PREDNISONE (1,011)
CANAGLIFLOZIN (1,007)
RITUXIMAB (891)
INFLIXIMAB (798)
TOCILIZUMAB (755)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Cellulitis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA